As of 10:30 AM on the 14th, Celltrion is trading at 364,500 KRW, up 0.97% from the previous day. This marks a 27.45% increase compared to November 17. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, institutional investors sold a net 26,000 shares, while individual investors have bought a net 321,762 shares over the past five days. Foreigners and institutions sold a net 323,215 shares and 7,287 shares, respectively.


On December 4, Celltrion was a market topic with the headline "Is Short Covering Starting... Merrill Lynch Buys 200,000 Shares."



※Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an article automation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing